Polaris Pharmaceuticals extends operations in Northern California

Vacaville Mayor Ron Rowlett (right) meets with Vacaville’s Polaris Principal Engineer Mary Scomona, Business Development Manager Jose Ortiz and Facility Director Matt Mitchell (left to right).

San Diego–based Polaris Pharmaceuticals has purchased 15 acres from the City of Vacaville, California, within the Vaca Valley Business Park. 

Polaris already has a contract development and manufacturing site in the city in addition to operations in San Diego and Chengdu, China. 

In Vacaville, the company plans to construct an additional biopharmaceutical manufacturing facility. 

Polaris established the Vacaville site in 2002, adding a cGMP facility for biologics in 2005 

“We are excited to expand our manufacturing and process research capabilities in Vacaville,” said Chris Huxsoll, senior vice president of operations of Polaris Pharmaceuticals, in a statement. 

Home to the non-profit C…

Read more
  • 0

An inside look at Northern California’s growing biomanufacturing hub 

Vacaville shown on Google Maps

Vacaville, Calif. is home to a burgeoning biotech hub.

And there’s more to Vacaville’s biomanufacturing industry than Genentech’s presence there. “Genentech is just one of the biotech companies to open in Vacaville,” said Don Burrus, the city’s director of economic development services. “We’ve had biomanufacturers here for almost 30 years.”

Genentech set up shop in the city, located 35 miles southeast of Sacramento, in the late 1990s. The company acquired land in the city in 1994.

More recently, Lexington, Mass.–based Agenus purchased 120 acres in the city.

When Burrus began working for the city in June 2020, he collaborated with economists and other economic development experts to analyze the city’s economic drivers.

“We were able to determine that biomanufacturing and advanced manufacturing were big economic drivers,” Burrus said.


Read more
  • 0

The hottest life science hubs in the U.S.

Boston at night [Photo by Lance Anderson on Unsplash]

Boston, San Francisco and San Diego remain the leading U.S. life science hubs — hauling in 70% of all the venture capital in the space last year, according to a new report from commercial real estate services company JLL.

Venture capital funding matters, according to JLL, because it fuels innovative companies that then require more real estate space. It’s little wonder that Boston and San Francisco led other clusters with respect to development, with 2.7 million square feet and 4.0 million square feet respectively under construction.

The U.S. is struggling through the COVID-19 pandemic and resulting recession. But JLL in its “2020 Life Sciences Real Estate Outlook” report expressed optimism when it comes to the life sciences sector. Key points in the report included:

The pandemic has sparked a race to create coronavirus tests, t…
Read more
  • 0